Healthy Persons Ages 65 Years and Older
Unvaccinated

*An 8-week interval between the first and second COVID-19 vaccine doses might be optimal for some people as it might reduce the rare risk of myocarditis and pericarditis associated with these vaccines.

+ If more than 8 weeks have elapsed since receipt of the first dose of Novavax, any 2024-2025 COVID-19 vaccine (i.e., Moderna, Novavax, or Pfizer-BioNTech) may be administered.

Reference: Clinical Guidance for COVID-19 Vaccination | CDC and 2024-2025 COVID-19 Vaccine Immunization Schedule for People 6 Months of Age and Older (cdc.gov